Proteros Biostructures GmbH. (3/29/10). "Press Release: Proteros Establishes Board of Directors and Appoints Leading Industry Experts". Martinsried.

	Region	Martinsried
	Country	Germany
	Organisation	Proteros Biostructures GmbH
	Group	Proteros (Group)
	Product	structural biology
	Product 2	drug discovery services

Proteros GmbH (“Proteros”) announces the formation of a Board of Directors which consists of leading experts with core competences in life sciences and corporate development. The Board will oversee all commercial and scientific activities and will support Proteros in its further corporate development and international expansion.

In order to accelerate its development and to continue its global expansion, Proteros, a major player in the field of structural biology and partner for integrated drug discovery services with annual growth rates of 30 per cent, has appointed board members with an impressive track record in industry. Chairman of the Board is Dr. Timm-H. Jessen, formerly with Sanofi Aventis, ex-CSO of Evotec AG and renowned representative of the life science industry. Dave Lemus, MBA, CFO of MorphoSys AG since 1998 and key driver for the growth of the company has been appointed deputy chairman. The Honorary President of the Board is Nobel Laureate Prof. Dr. Robert Huber, co-founder and active scientific advisor of Proteros. The Board’s expertise is complemented by the profound experience of Dipl.-Ing. Ingo Köhler, CEO of VISCON and renowned advisor of German Pharma, Diagnostic and Biotech companies, Dr. Berthold Hinzen, Head of Global Business Development and Licensing General Medicine of Bayer-Schering Pharma AG, and Prof. Dr. Andre Schmutte, expert for industry process optimization and Six Sigma Management Consultant.

Dr. Torsten Neuefeind, CEO and co-founder of Proteros said: “We are grateful to have such a distinguished and internationally renowned group of experts on our Board supporting the next stages of Proteros’ international development.” Dr. Jessen emphasized: “I am very proud to chair this highly experienced top-class Board of Directors and to support the continued success of Proteros. I am convinced that Proteros will continue to become an indispensable partner for the Life Sciences industry and a global player in the pre-clinical drug discovery market.”

About Proteros biostructures GmbH:

Proteros is a privately held company which provides services and proprietary technologies to support integrated drug discovery within life sciences. The company accelerates and improves protein structure analysis and structure-based drug discovery with its expertise, industrialized processes and unique technologies for crystallography and fragment-based lead generation. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services for more than 60 pharmaceutical and biotechnology clients in North America, Europe and Japan.

Contact:

Proteros biostructures GmbH
Kurt Herrenknecht, Ph.D.
Am Klopferspitz 19
82152 Martinsried
Germany
Phone: +49 (0) 89 7007 61 - 0
Fax: +49 (0) 89 7007 61 - 15
E-Mail: herrenknecht@proteros.com
Internet: www.proteros.com

Record changed: 2011-11-27

Follow Us!

Top News

Upcoming Events

Associations

Partners

Proteros Biostructures GmbH. (3/29/10). "Press Release: Proteros Establishes Board of Directors and Appoints Leading Industry Experts". Martinsried.

More documents for Proteros (Group)